Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results.

Current HIV research - 1 Dec 2011

Ortu Massimiliano, Vitiello Paola, Adorni Fulvio, Rossotti Roberto, Di Vincenzo Paola, Vigano Ottavia, Galli Massimo, Rusconi Stefano

Abstract excerpt

BACKGROUND: Since recent observations demonstrated that extended resistance to protease inhibitors, nucleosidic and non - nucleosidic retrotranscriptase inhibitors (PI, NRTI, NNRTI) is a marker of disease progression and death, it is a matter of the greatest importance that experienced human immunodeficiency virus (HIV) - infected patients with limited therapeutic options receive a suppressive therapy pending the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Logistic Models

Source

Identifiers

PMID: 22211659
DOI: 10.2174/157016211798998790

Genes

GSS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results.PMID 22211659Read ↗

Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.Semantic proximity Read ↗

Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.Semantic proximity Read ↗

Historical resistance profile helps to predict salvage failure.Semantic proximity Read ↗

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.Semantic proximity Read ↗

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.Semantic proximity Read ↗

Predicting antiretroviral drug resistance from the latest or the cumulative genotype.Semantic proximity Read ↗

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment.Semantic proximity Read ↗

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.Semantic proximity Read ↗

Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.